Serum Magnesium Levels and their Association with Cardiac Complications and In-Hospital Mortality in Acute Myocardial Infarction Patients
International Journal of Current Pharmaceutical Review and Research · 30.04.2026 · 18 (04)
DOI: 10.25258/ijcpr.18.4.130 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.04.2026. Verfasst von M. Sharana und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Acute myocardial infarction remains a leading cause of cardiovascular mortality worldwide. Magnesium, an essential cofactor in numerous enzymatic reactions, plays a critical role in cardiac electrophysiology and myocardial function. Hypomagnesemia has been associated with increased risk of ventricular arrhythmias and adverse outcomes in critically ill patients. However, the prognostic significance of serum magnesium levels at admission in acute myocardial infarction patients remains incompletely understood. This study aimed to evaluate the relationship between admission serum magnesium levels and the occurrence of cardiac complications and in-hospital mortality in patients with acute myocardial infarction.
Methods
This prospective observational study was conducted over eighteen months and included 160 patients admitted with acute myocardial infarction. Serum magnesium levels were measured at admission, and patients were categorized into hypomagnesemia and normomagnesemia groups based on serum magnesium levels below or above 1.7 mg/dL respectively. All patients were monitored for the development of cardiac complications including ventricular arrhythmias, heart failure, cardiogenic shock, and in-hospital mortality. Statistical analysis was performed using appropriate tests with p-value less than 0.05 considered significant.
Results
Hypomagnesemia was detected in 56.25% of patients at admission. The hypomagnesemia group demonstrated significantly higher incidence of ventricular tachycardia (31.11% vs 12.86%, p=0.004), ventricular fibrillation (17.78% vs 4.29%, p=0.007), heart failure (42.22% vs 21.43%, p=0.003), and cardiogenic shock (20.00% vs 7.14%, p=0.018). In-hospital mortality was substantially higher in hypomagnesemic patients (23.33% vs 8.57%, p=0.011). Serum magnesium levels showed significant negative correlation with cardiac complications.
Conclusion
Hypomagnesemia at admission was independently associated with increased cardiac complications and in-hospital mortality in acute myocardial infarction patients. Routine measurement of serum magnesium levels may serve as a valuable prognostic marker for risk stratification in this population.
Zitieren
APA
Sharana, M., & B., L. S. (2026). Serum Magnesium Levels and their Association with Cardiac Complications and In-Hospital Mortality in Acute Myocardial Infarction Patients. International Journal of Current Pharmaceutical Review and Research, 18(04). https://doi.org/10.25258/ijcpr.18.4.130
Vancouver
Sharana M, B. LS. Serum Magnesium Levels and their Association with Cardiac Complications and In-Hospital Mortality in Acute Myocardial Infarction Patients. International Journal of Current Pharmaceutical Review and Research. 2026;18(04). doi:10.25258/ijcpr.18.4.130
BibTeX
@article{Sharana2026,
author = {Sharana, M. and B., Lohitashwa S.},
title = {Serum Magnesium Levels and their Association with Cardiac Complications and In-Hospital Mortality in Acute Myocardial Infarction Patients},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {04},
doi = {10.25258/ijcpr.18.4.130}
}
EUVIMED